CORC

在结果中检索

CORC

浏览/检索结果: 共15条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Hydrochlorothiazide Test as a Tool in the Diagnosis of Gitelman Syndrome in Chinese Patients 期刊论文
2018, 卷号: 9, 页码: 559
作者:  Peng, Xiaoyan;  Zhao, Bingbin;  Zhang, Lei;  Jiang, Lanping;  Yuan, Tao
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Hypokalemia, hypomagnesemia, hypocalciuria, and recurrent tetany: Gitelman syndrome in a Chinese pedigree and literature review 期刊论文
CLINICAL CASE REPORTS, 2017, 卷号: 5, 期号: 5
作者:  Xia, Ming-Feng;  Bian, Hua;  Liu, Hong;  Wu, Hui-Juan;  Zhang, Zhi-Gang
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Outcomes by hypomagnesemia (hypomag) in the randomized phase III ASPECCT trial of patients (pts) with chemofractory wild-type (WT) ERAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2016, 卷号: 34
作者:  Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Venkatasatya A., Thomas S.A., Tjulandin S., Guan X., Hoang T., Hei Y.J., Price T.J.
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Outcomes by hypomagnesemia in the randomized phase III ASPECCT trial in patients with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2016
作者:  Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Guan X., Peeters M.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13
Outcomes by hypomagnesemia (hypomag) in the randomized phase III ASPECCT trial of patients (pts) with chemofractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC). 会议论文
作者:  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano;  Ruff, Paul
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/06
Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): outcomes by hypomagnesemia (hypomag) in ASPECCT 会议论文
作者:  Peeters, Marc;  Price, Timothy Jay;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13
Randomized phase III study of panitumumab (pmab) vs. cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT. 会议论文
作者:  Price, Timothy Jay;  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13
Randomized phase III study of panitumumab (pmab) vs. cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Price T.J., Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Peeters M., Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A.L., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wildtype (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Peeters M., Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A.L., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace